Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S&S Healthcare HoldingROCO:4198 -5.11%54 Median PS Value is NT$25.63 as of Jul. 19, 2026, which is 100% below its 10-year median of 1.06. GuruFocus rates ROCO:4198 with a GF Score™ of 54/100 and a GF Value™ of NT$23.68 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 336 Medical Devices & Instruments companies, S&S Healthcare Holding ranks worse than 89.58% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for S&S Healthcare Holding's Median PS Value or its related term are showing as below:
ROCO:4198'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.7 Med: 1.06 Max: 1.48
Current: 1.48
During the past 13 years, the highest Price to Median PS Value of S&S Healthcare Holding was 1.48. The lowest was 0.70. And the median was 1.06.
ROCO:4198's Price-to-Median-PS-Value is ranked worse than 89.58% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs ROCO:4198: 1.48
S&S Healthcare Holding (ROCO:4198) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
S&S Healthcare Holding's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
38.05
/
25.63
=
1.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S&S Healthcare Holding Median PS Value Related Terms
S&S Healthcare Holding Median PS Value Historical Data
* Premium members only.
The historical data trend for S&S Healthcare Holding's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4198 vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, S&S Healthcare Holding's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S&S Healthcare Holding Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where S&S Healthcare Holding's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.0188.
S&S Healthcare Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$8.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S&S Healthcare Holding (ROCO:4198) has a Median PS Value of NT$25.63 as of Jul. 19, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on S&S Healthcare Holding and its competitors. This is 2318% above median its historical median of 1.06. Over the past decade, S&S Healthcare Holding's Median PS Value has ranged from 0.70 to 1.48. According to the industry distribution chart, S&S Healthcare Holding ranks #301 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 89.6%.
Is S&S Healthcare Holding's Median PS Value too high?
S&S Healthcare Holding's current Median PS Value of NT$25.63 is 2318% above median its 10-year median of 1.06. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 1.48. Based on the distribution chart, S&S Healthcare Holding ranks #301 out of 336 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, S&S Healthcare Holding has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does S&S Healthcare Holding's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, S&S Healthcare Holding ranks #301 out of 336 companies for Median PS Value. This places S&S Healthcare Holding in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, S&S Healthcare Holding's own Median PS Value has ranged from 0.70 to 1.48 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on S&S Healthcare Holding and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S&S Healthcare Holding's current Median PS Value is NT$25.63, which is 2318% above median its own 10-year median of 1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S&S Healthcare Holding stock overvalued right now?
Based on GuruFocus' analysis, S&S Healthcare Holding (ROCO:4198) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$23.68, compared to a current price of NT$38.05 — trading 60.7% above its estimated fair value. The current Median PS Value is NT$25.63, which is 2318% above median its 10-year median of 1.06. S&S Healthcare Holding's overall GF Score™ is 54/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For S&S Healthcare Holding (ROCO:4198), the current Median PS Value is NT$25.63 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is S&S Healthcare Holding (ROCO:4198) Overvalued in 2026?
Based on GuruFocus' analysis, S&S Healthcare Holding stock appears to be overvalued.
The current stock price of NT$38.05 is trading 60.7% above its estimated GF Value™ of NT$23.68.
GuruFocus considers S&S Healthcare Holding to be Significantly Overvalued.
Key valuation signals for ROCO:4198:
Median PS Value: NT$25.63 (2318% above median its 10-year median of 1.06)
GF Value™: NT$23.68 vs. price of NT$38.05 (60.7% above fair value)
No single metric tells the full story. See the ROCO:4198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.
54GF Score
Get the complete analysis for ROCO:4198
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4198 has been successfully added to your 
